A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen
Titel:
A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen
Auteur:
Ruff, Paul Vorobiof, D. A. Jordaan, J. P. Demetriou, G. S. Moodley, S. D. Nosworthy, A. L. Werner, I. D. Raats, J. Burgess, L. J.